These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 5530049)

  • 1. [STA (serum thrombotic accelerator) activity, with special reference to changes in the STA activity in the serum from patients with hypercoagulable state. 2. Clinical studies].
    Nakamura Y
    Nihon Ketsueki Gakkai Zasshi; 1970 Apr; 33(2):256-72. PubMed ID: 5530049
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies on the STA (serum thrombotic accelerator) activity, with special reference to changes in the STA activity in the serum from patients with hypercoagulable state. 1. Experimental study].
    Nakamura Y
    Nihon Ketsueki Gakkai Zasshi; 1970 Apr; 33(2):245-55. PubMed ID: 5530048
    [No Abstract]   [Full Text] [Related]  

  • 3. [Molecular marker for detecting hypercoagulable state].
    Magari Y; Mizunaga S; Ito M; Shibata T; Ito H
    Rinsho Byori; 1994 Jan; 42(1):22-33. PubMed ID: 8107279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative assessment of certain indices of the blood coagulating and anticoagulating systems in patients with hypertension and atherosclerosis].
    Protasova NS; Sokratova GP
    Ter Arkh; 1968 Jun; 40(6):69-71. PubMed ID: 5739213
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of ABO blood groups in dynamic coagulation and thrombus formation in vascular disease. An in vitro study.
    Dintenfass L
    Haematologia (Budap); 1971; 5(3):205-16. PubMed ID: 5128745
    [No Abstract]   [Full Text] [Related]  

  • 6. Platelet factor 4 levels in patients with coronary artery disease.
    White GL; Marouf AA
    J Lab Clin Med; 1981 Mar; 97(3):369-78. PubMed ID: 6970238
    [No Abstract]   [Full Text] [Related]  

  • 7. [Changes in the blood coagulation and anticoagulation system in patients with myocardial infarction and angina pectoris in omephin therapy].
    Orlova NP
    Sov Med; 1966 Feb; 29(2):108-12. PubMed ID: 5992593
    [No Abstract]   [Full Text] [Related]  

  • 8. Carbohydrate metabolism and plasma levels of insulin and glucagon in patients with atherosclerotic vascular disease.
    Carreiro-Pousada JM; Garrote FJ; Rovira A; Herrera-Pombo JL; Valverde I
    Diabete Metab; 1988; 14(3):277-82. PubMed ID: 3044864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group.
    Thompson SG; Kienast J; Pyke SD; Haverkate F; van de Loo JC
    N Engl J Med; 1995 Mar; 332(10):635-41. PubMed ID: 7845427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet survival studies in man. With special reference to thrombosis and atherosclerosis.
    Abrahamsen AF
    Scand J Haematol Suppl; 1968; 3():1-53. PubMed ID: 5253463
    [No Abstract]   [Full Text] [Related]  

  • 11. [Assessment of platelet factor IV for the evaluation of platelet function in patients with ischemic cardiopathy].
    de Teresa E; Lorenz MP; Vera A; Ortigosa J; Chamorro JL; de Artaza M
    Rev Esp Cardiol; 1981; 34(4):311-5. PubMed ID: 7323384
    [No Abstract]   [Full Text] [Related]  

  • 12. [Studies on blood clotting disorders in patients with myocardial infarction and angina pectoris].
    Olszewski W; Laskowski S; Jeziorny J; Kogucki S
    Pol Tyg Lek; 1968 Dec; 23(49):1885-7. PubMed ID: 5704215
    [No Abstract]   [Full Text] [Related]  

  • 13. Ten-year mortality and morbidity related to serum cholesterol. A follow-up of 3.751 men aged 40-49.
    Westlund K; Nicolaysen R
    Scand J Clin Lab Invest Suppl; 1972; 127():1-24. PubMed ID: 4640618
    [No Abstract]   [Full Text] [Related]  

  • 14. [Serum lipids and coagulation tests in coronary diseases].
    Chaudhuri S
    Pathol Biol (Paris); 1972 Nov; 20(21):881-6. PubMed ID: 4566243
    [No Abstract]   [Full Text] [Related]  

  • 15. [Primary hyperlipemia: intra-platelet and serum NEFA. Their relation to hypercoagulability].
    Yañez-Polo MA; Muñoz-González J; C-Soriguer-Escofet F; Causse-Prado M; Lissen-Otero E; León-Castro J
    Minerva Med; 1974 Apr; 65(25):1329-39. PubMed ID: 4849473
    [No Abstract]   [Full Text] [Related]  

  • 16. [Relation between the hemostatic process and thrombosis. A clinical problem].
    Ponari O; Dettori AG
    Recenti Prog Med; 1968 Sep; 45(3):259-82. PubMed ID: 4916345
    [No Abstract]   [Full Text] [Related]  

  • 17. [Studies on the adhesive capacity of thrombocytes in patients with afflictions of the circulatory system (author's transl)].
    Köstering H; Walther C; Grüne M; König F; Völker P
    Z Klin Chem Klin Biochem; 1973 May; 11(5):215-9. PubMed ID: 4804175
    [No Abstract]   [Full Text] [Related]  

  • 18. [Behavior of plasmatic coagulation factors in various stages of coronary sclerosis, confirmed by coronarography].
    Nelius D; Parsi RA; Stürmer U
    Z Alternsforsch; 1973; 27(3):277-82. PubMed ID: 4771228
    [No Abstract]   [Full Text] [Related]  

  • 19. [Coagulation disorders in patients with liver cirrhosis].
    Ihle E; Schimmelpfennig W
    Z Arztl Fortbild (Jena); 1983; 77(22):929-34. PubMed ID: 6659589
    [No Abstract]   [Full Text] [Related]  

  • 20. [Blood viscosity in angina pectoris and acute myocardial infarct].
    Belousov IuB; Liusov VA; Zakharchenko VN; Larionov SM; Chuev IuV
    Kardiologiia; 1973 Mar; 13(3):5-10. PubMed ID: 4780477
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.